Humana (NYSE:HUM) Reaches New 52-Week High – Time to Buy?

Humana Inc. (NYSE:HUM) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $380.86 and last traded at $369.78, with a volume of 1697078 shares changing hands. The stock had previously closed at $380.26.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. The Goldman Sachs Group increased their price target on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research note on Thursday, April 30th. JPMorgan Chase & Co. increased their price target on Humana from $214.00 to $316.00 and gave the company a “neutral” rating in a research note on Monday, June 8th. Raymond James Financial reiterated an “outperform” rating and set a $260.00 price objective on shares of Humana in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft downgraded Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, May 20th. Finally, Jefferies Financial Group upgraded Humana from a “buy” rating to a “buy” rating in a research report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $291.35.

Humana Price Performance

The stock has a fifty day moving average price of $275.78 and a 200-day moving average price of $239.13. The company has a market cap of $44.40 billion, a PE ratio of 39.55, a price-to-earnings-growth ratio of 2.17 and a beta of 0.76. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company’s revenue for the quarter was up 23.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities analysts expect that Humana Inc. will post 9.04 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.0%. Humana’s dividend payout ratio is presently 37.86%.

Institutional Trading of Humana

Hedge funds have recently modified their holdings of the business. Montag A & Associates Inc. lifted its holdings in shares of Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares in the last quarter. CoreCap Advisors LLC lifted its holdings in shares of Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac purchased a new stake in shares of Humana in the fourth quarter valued at $27,000. Reflection Asset Management purchased a new stake in shares of Humana during the fourth quarter worth $29,000. Finally, Rosenberg Matthew Hamilton raised its holdings in shares of Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 68 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.